Search by Drug Name or NDC

    NDC 00078-0607-89 Gilenya 0.5 mg/1 Details

    Gilenya 0.5 mg/1

    Gilenya is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is FINGOLIMOD HYDROCHLORIDE.

    Product Information

    NDC 00078-0607
    Product ID 0078-0607_ca55becd-c1e3-439a-8563-d6a60b7806e9
    Associated GPIs 62407025100120
    GCN Sequence Number 066709
    GCN Sequence Number Description fingolimod HCl CAPSULE 0.5 MG ORAL
    HIC3 H0E
    HIC3 Description AGENTS TO TREAT MULTIPLE SCLEROSIS
    GCN 29073
    HICL Sequence Number 037180
    HICL Sequence Number Description FINGOLIMOD HCL
    Brand/Generic Brand
    Proprietary Name Gilenya
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fingolimod hcl
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name FINGOLIMOD HYDROCHLORIDE
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022527
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0607-89 (00078060789)

    NDC Package Code 0078-0607-89
    Billing NDC 00078060789
    Package 7 CAPSULE in 1 CARTON (0078-0607-89)
    Marketing Start Date 2010-09-21
    NDC Exclude Flag N
    Pricing Information N/A